Sanofi, the French pharmaceutical giant has revealed plans to make its vaccine again COVID19 available to all countries with USA having a lion share because they funded the research.
French pharmaceutical giant Sanofi plans to make any vaccine it develops against the novel coronavirus available to all
“The vaccine against COVID-19 will be made available to the public at large, regardless of nationality,” the company’s director general Paul Hudson said, according to a tweet from Sanofi France on Wednesday evening.
The message came after Hudson, in an interview with Bloomberg, said the U.S. would have priority because they were the first in line to fund the company’s research.
“The US government has the right to the largest pre-order because it’s invested in taking the risk,” Hudson told Bloomberg.
In April, Sanofi and the pharmaceutical company GlaxoSmithKline both said they wanted to work together on a vaccine against the novel coronavirus. If tests are successful, a vaccine could be available in the second half of 2021.
Sanofi said in its Wednesday tweet that its teams are making efforts to accelerate the development of a vaccine.
Lai Mohammed Inspects Tallest Flag Pole In Nigeria In Jigawa (Photos)
#BBNaijaReunion: You didn’t even last 5 seconds, I left you in bed – Ka3na tackle Praise (Video)
#BBNaijaReunion: “You Are Not Man Enough!” – TBaj Confronts Prince and Vee (Video)
Actor, Okon Lagos tackles hotels who paste “Cars parked at owners risk” signage in their premises
‘You Can’t Bring A Good Man Down’ – Ighalo Writes After His Wife, Sonia, Called Him Out on IG
#BBNaijaReunion: I wanted loyalty not relationship, Nengi tells Ozo, Prince
#BBNaijaReunion: I fell out with Dorathy because of Ozo – Nengi
ASUU to embark on fresh strike
- Sports1 day ago
#Euro2020: Ronaldo called “a fool” for trying to disgrace Rudiger
- News1 day ago
Meet 16-yr-old girl who faked own kidnap to avoid studying Medicine
- News2 days ago
Biafra: Igbos will lose more if Nigeria breaks up – Rochas Okorocha
- News2 days ago
Nigeria has been excluded from U.S.’ $91 million COVID-19 response fund to Africa